VIRAX BIOLABS GROUP LTD (VRAX) Stock Analyst Earnings Estimates
NASDAQ:VRAX - Nasdaq - KYG9495L1251 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 8.56K | 156.42K 1,727.34% | 8.242M 5,169.15% | 13.762M 66.97% | |
| EBITDA YoY % growth | N/A | N/A | -6.003M -2.67% | -1.003M 83.30% | 612.5K 161.09% | |
| EBIT YoY % growth | -1.73M -170.31% | -5.733M -231.37% | -6.106M -6.51% | -1.004M 83.56% | 612.5K 161.03% | |
| Operating Margin | N/A | -66,971.50% | -3,903.66% | -12.18% | 4.45% | |
| EPS YoY % growth | N/A | N/A | N/A -5.56% | -0.06 68.42% | 0.04 166.67% |
All data in USD
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.61 68.42% |
| Revenue Q2Q % growth | N/A |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 4.95K -93.53% | % | ||
| Q4 2024 Q2Q % growth | 79.92K 2,754.29% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |